These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31398669)

  • 1. Continuous infusion of physostigmine in patients with perioperative septic shock: A pharmacokinetic/pharmacodynamic study with population pharmacokinetic modeling.
    Pinder N; Zimmermann JB; Gastine S; Würthwein G; Hempel G; Bruckner T; Hoppe-Tichy T; Weigand MA; Swoboda S
    Biomed Pharmacother; 2019 Oct; 118():109318. PubMed ID: 31398669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of physostigmine on recovery from septic shock following intra-abdominal infection - Results from a randomized, double-blind, placebo-controlled, monocentric pilot trial (Anticholium® per Se).
    Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Larmann J; Knebel P; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S; Zimmermann JB
    J Crit Care; 2019 Aug; 52():126-135. PubMed ID: 31035187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?
    Öbrink-Hansen K; Juul RV; Storgaard M; Thomsen MK; Hardlei TF; Brock B; Kreilgaard M; Gjedsted J
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7018-26. PubMed ID: 26349823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revival of physostigmine - a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients.
    Pinder N; Zimmermann JB; Hofer S; Brenner T; Weigand MA; Gubbe U; Hoppe-Tichy T; Swoboda S
    Clin Chem Lab Med; 2015 Jul; 53(8):1259-64. PubMed ID: 25565546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of oral fludrocortisone in septic shock.
    Polito A; Hamitouche N; Ribot M; Polito A; Laviolle B; Bellissant E; Annane D; Alvarez JC
    Br J Clin Pharmacol; 2016 Dec; 82(6):1509-1516. PubMed ID: 27416887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease.
    Asthana S; Greig NH; Hegedus L; Holloway HH; Raffaele KC; Schapiro MB; Soncrant TT
    Clin Pharmacol Ther; 1995 Sep; 58(3):299-309. PubMed ID: 7554703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock.
    Borsuk-De Moor A; Rypulak E; Potręć B; Piwowarczyk P; Borys M; Sysiak J; Onichimowski D; Raszewski G; Czuczwar M; Wiczling P
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration.
    Somani SM
    Biopharm Drug Dispos; 1989; 10(2):187-203. PubMed ID: 2706318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs.
    Giacobini E; Somani S; McIlhany M; Downen M; Hallak M
    Neuropharmacology; 1987 Jul; 26(7B):831-6. PubMed ID: 3658115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity study of continuous administration of physostigmine salicylate.
    Lim DK; Ito Y; Stewart T; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1988 Nov; 31(3):627-31. PubMed ID: 3251246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of epinephrine in patients with septic shock: modelization and interaction with endogenous neurohormonal status.
    Abboud I; Lerolle N; Urien S; Tadié JM; Leviel F; Fagon JY; Faisy C
    Crit Care; 2009; 13(4):R120. PubMed ID: 19622169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome.
    Yang S; Dumitrescu TP
    Drugs R D; 2017 Mar; 17(1):145-158. PubMed ID: 28004376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type.
    Möller H-J ; Hampel H; Hegerl U; Schmitt W; Walter K
    Pharmacopsychiatry; 1999 May; 32(3):99-106. PubMed ID: 10463377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements.
    Ulldemolins M; Soy D; Llaurado-Serra M; Vaquer S; Castro P; Rodríguez AH; Pontes C; Calvo G; Torres A; Martín-Loeches I
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5520-8. PubMed ID: 26124172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects.
    Greig NH; Ruckle J; Comer P; Brownell L; Holloway HW; Flanagan DR; Canfield CJ; Burford RG
    Curr Alzheimer Res; 2005 Oct; 2(4):483-92. PubMed ID: 16248851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.
    Chidambaran V; Venkatasubramanian R; Sadhasivam S; Esslinger H; Cox S; Diepstraten J; Fukuda T; Inge T; Knibbe CAJ; Vinks AA
    Paediatr Anaesth; 2015 Sep; 25(9):911-923. PubMed ID: 25975390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers.
    Mant T; Troetel WM; Imbimbo BP
    J Clin Pharmacol; 1998 Jul; 38(7):610-7. PubMed ID: 9702845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.